← Eichor
Condition: Systemic Lupus Erthematosus Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Systemic Lupus Erthematosus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116A Study of GR1803 in Systemic Lupus Erythematosus
Phase 1/Phase 2 · 1 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT07348055UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Phase 1 · 1 location(s) · LiveKidney.Bio · NCT06737380Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07507201The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07278609A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Phase 1 · 1 location(s) · Hinge Bio · NCT07491900Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus
Phase 1 · 1 location(s) · Biocad · NCT07136389Rare AutoImmune SElf-management Programme Development
Phase N/A · 1 location(s) · University of the West of England · NCT066428702-HOBA in Systemic Lupus Erythematosus
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT07225543Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
NA · 1 location(s) · University of California, San Diego · NCT07713940CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07586267COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.